Country for PR: United States
Contributor: PR Newswire New York
Wednesday, October 06 2021 - 14:00
AsiaNet
ArisGlobal LifeSphere(R) MultiVigilance is selected by Asahi Kasei Pharma
MIAMI and TOKYO, Oct. 6, 2021 /PRNewswire-AsiaNet/ --

Asahi Kasei Pharma Corp. has selected LifeSphere(R) MultiVigilance ( 
https://c212.net/c/link/?t=0&l=en&o=3313917-1&h=479470560&u=https%3A%2F%2Fwww.arisglobal.com%2Fproducts%2Flifesphere-multivigilance%2F%3Futm_medium%3Dcpc%26utm_source%3Dadwords%26utm_campaign%3DSO-Brand%26gclid%3DCjwKCAjw_o-HBhAsEiwANqYhp9GtpStSttJBzyUNpLUWPVsgTKM6YnwZsNtfkIIwsHWPNSYsEnDvjBoC5XgQAvD_BwE&a=LifeSphere%C2%AE+MultiVigilance 
) as a new safety database with the purpose of building a system that supports 
efficiency, regulatory compliance, and global collaboration over the long term. 
In addition, Asahi Kasei Pharma will adopt ArisGlobal's rapid migration 
methodology, which has been successfully embraced by many of the world's 
leading life sciences companies when transitioning from their legacy safety 
systems. 

Logo - https://mma.prnewswire.com/media/1510670/ArisGlobal_Logo.jpg 

"We are very pleased that Asahi Kasei Pharma will adopt ArisGlobal's 
multi-tenant LifeSphere(R) Safety suite," says Pat Jenakanandhini, Chief 
Product Officer at ArisGlobal. "We offer the world's largest and most 
innovative multi-tenant safety cloud. Asahi Kasei Pharma is an example of how 
customers in Japan and globally can meet a wide range of requirements for 
patient safety by leveraging our leading technology.

About ArisGlobal

ArisGlobal is transforming the way today's most successful Life Sciences 
companies develop breakthroughs and bring new products to market. Our 
end-to-end drug development technology platform, LifeSphere(R), integrates our 
proprietary Nava(R) cognitive computing engine to automate all core functions 
of the drug development lifecycle. Designed with deep expertise and a long-term 
perspective that spans more than 30 years, LifeSphere(R) is a unified platform 
that boosts efficiency, ensures compliance, delivers actionable insights, and 
lowers total cost of ownership through multi-tenant SaaS architecture.

Headquartered in the United States, ArisGlobal has regional offices in Europe, 
India, Japan, and China.          
To learn more about ArisGlobal and its products, please visit the ArisGlobal 
homepage. https://www.arisglobal.com/

About Asahi Kasei Pharma

In accordance with the Asahi Kasei Pharma Mission "To sincerely care for each 
individual life and solve their unmet medical needs with a wealth of ideas and 
solid science," Asahi Kasei Pharma operates pharmaceutical and diagnostic 
businesses in the Health Care Business Unit of the Asahi Kasei Group. Asahi 
Kasei Pharma has developed numerous innovative drugs in the field of 
orthopedics, acute care, neurology (including pain), and immunology, 
contributing to society by providing such products to patients who suffer from 
diseases. For more information, please visit 
https://www.asahikasei-pharma.co.jp/en/ 

SOURCE: ArisGlobal

CONTACT: Tiffany Murray, arisglobal@blastmedia.com
Translations

Japanese